Literature DB >> 11265923

Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers.

P S Jensen1, S P Hinshaw, J M Swanson, L L Greenhill, C K Conners, L E Arnold, H B Abikoff, G Elliott, L Hechtman, B Hoza, J S March, J H Newcorn, J B Severe, B Vitiello, K Wells, T Wigal.   

Abstract

In 1992, the National Institute of Mental Health and 6 teams of investigators began a multisite clinical trial, the Multimodal Treatment of Attention-Deficit Hyperactivity Disorder (MTA) study. Five hundred seventy-nine children were randomly assigned to either routine community care (CC) or one of three study-delivered treatments, all lasting 14 months. The three MTA treatments-monthly medication management (usually methylphenidate) following weekly titration (MedMgt), intensive behavioral treatment (Beh), and the combination (Comb)-were designed to reflect known best practices within each treatment approach. Children were assessed at four time points in multiple outcome. Results indicated that Comb and MedMgt interventions were substantially superior to Beh and CC interventions for attention-deficit hyperactivity disorder symptoms. For other functioning domains (social skills, academics, parent-child relations, oppositional behavior, anxiety/depression), results suggested slight advantages of Comb over single treatments (MedMgt, Beh) and community care. High quality medication treatment characterized by careful yet adequate dosing, three times daily methylphenidate administration, monthly follow-up visits, and communication with schools conveyed substantial benefits to those children that received it. In contrast to the overall study findings that showed the largest benefits for high quality medication management (regardless of whether given in the MedMgt or Comb group), secondary analyses revealed that Comb had a significant incremental effect over MedMgt (with a small effect size for this comparison) when categorical indicators of excellent response and when composite outcome measures were used. In addition, children with parent-defined comorbid anxiety disorders, particularly those with overlapping disruptive disorder comorbidities, showed preferential benefits to the Beh and Comb interventions. Parental attitudes and disciplinary practices appeared to mediate improved response to the Beh and Comb interventions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11265923     DOI: 10.1097/00004703-200102000-00008

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  98 in total

1.  ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.

Authors:  Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser
Journal:  Pediatrics       Date:  2011-10-16       Impact factor: 7.124

2.  Use of an Internet portal to improve community-based pediatric ADHD care: a cluster randomized trial.

Authors:  Jeffery N Epstein; Joshua M Langberg; Philip K Lichtenstein; Rebecca Kolb; Mekibib Altaye; John O Simon
Journal:  Pediatrics       Date:  2011-10-17       Impact factor: 7.124

Review 3.  Pharmacologic treatment of attention-deficit hyperactivity disorder.

Authors:  Donald E Greydanus
Journal:  Indian J Pediatr       Date:  2005-11       Impact factor: 1.967

4.  New developments in the treatment of attention-deficit/hyperactivity disorder in primary care.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

Review 5.  A Developmental Psychopathology Perspective on ADHD and Comorbid Conditions: The Role of Emotion Regulation.

Authors:  Elizabeth A Steinberg; Deborah A G Drabick
Journal:  Child Psychiatry Hum Dev       Date:  2015-12

Review 6.  Ten good reasons to consider biological processes in prevention and intervention research.

Authors:  Theodore P Beauchaine; Emily Neuhaus; Sharon L Brenner; Lisa Gatzke-Kopp
Journal:  Dev Psychopathol       Date:  2008

Review 7.  Personal reflections on observational and experimental research approaches to childhood psychopathology.

Authors:  Judith L Rapoport
Journal:  J Child Psychol Psychiatry       Date:  2008-11-01       Impact factor: 8.982

8.  The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Lenard Adler; Russell Barkley; Joseph Biederman; C Keith Conners; Olga Demler; Stephen V Faraone; Laurence L Greenhill; Mary J Howes; Kristina Secnik; Thomas Spencer; T Bedirhan Ustun; Ellen E Walters; Alan M Zaslavsky
Journal:  Am J Psychiatry       Date:  2006-04       Impact factor: 18.112

9.  Racial and Ethnic Differences in ADHD Treatment Quality Among Medicaid-Enrolled Youth.

Authors:  Janet R Cummings; Xu Ji; Lindsay Allen; Cathy Lally; Benjamin G Druss
Journal:  Pediatrics       Date:  2017-05-16       Impact factor: 7.124

10.  Assessing treatment outcomes in attention-deficit/hyperactivity disorder: a narrative review.

Authors:  Jeffery N Epstein; Margaret D Weiss
Journal:  Prim Care Companion CNS Disord       Date:  2012-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.